MetaADEDB 2.0 @ LMMD
Fluticasone
(WMWTYOKRWGGJOA-CENSZEJFSA-N)
Structure
SMILES
FCSC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Type(s)
Approved
Molecular Formula:
C25H31F3O5S
Molecular Weight:
500.571
Log P:
4.4300
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
105.97
CAS Number(s):
80474-14-2
Synonym(s)
1.
Fluticasone
2.
Cutivate
3.
Flixonase
4.
Flixotide
5.
Flonase
6.
Flovent
7.
Flovent HFA
8.
Fluticasone Propionate
9.
HFA, Flovent
10.
Propionate, Fluticasone
External Link(s)
MeSHD000068298
PubChem Compound444036
BindingDB50354849
ChEBI31441
CHEMBLCHEMBL1473
DrugBankDB00588
DrugCentral1225
IUPHAR/BPS Guide to PHARMACOLOGY7080
KEGGdr:D01708
ZINC3920027
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 2099
Canada Vigilance: 116
Canada Vigilance
OFFSIDES
US FAERS
2EpistaxisFAERS: 1066
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
3Product quality issueFAERS: 644
Canada Vigilance: 6
Canada Vigilance
US FAERS
4Device use errorFAERS: 598US FAERS
5HeadacheFAERS: 554
Canada Vigilance: 5
Canada Vigilance
US FAERS
6Wrong technique in product usage processFAERS: 531US FAERS
7AnosmiaFAERS: 351US FAERS
8Wrong technique in device usage processFAERS: 335US FAERS
9Nasal discomfortFAERS: 331US FAERS
10Product use issueFAERS: 319US FAERS
11Product use in unapproved indicationFAERS: 276
Canada Vigilance: 1
Canada Vigilance
US FAERS
12HypersensitivityFAERS: 245
Canada Vigilance: 7
Canada Vigilance
US FAERS
13MalaiseFAERS: 240
Canada Vigilance: 6
Canada Vigilance
US FAERS
14Drug dose omissionFAERS: 238US FAERS
15DizzinessFAERS: 237
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
16Pharmaceutical product complaintFAERS: 236OFFSIDES
US FAERS
17AsthmaFAERS: 208
Canada Vigilance: 23
Canada Vigilance
OFFSIDES
US FAERS
18AgeusiaFAERS: 206
Canada Vigilance: 2
Canada Vigilance
US FAERS
19Accidental exposure to productFAERS: 198US FAERS
20Drug administration errorFAERS: 180US FAERS
21Oropharyngeal painFAERS: 178
Canada Vigilance: 4
Canada Vigilance
US FAERS
22NauseaFAERS: 154
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
23DysphoniaFAERS: 151
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
24SneezingFAERS: 145US FAERS
25DysgeusiaFAERS: 141
Canada Vigilance: 3
Canada Vigilance
US FAERS
26OverdoseFAERS: 140
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Incorrect dose administeredFAERS: 138
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Product cleaning inadequateFAERS: 135US FAERS
29Inappropriate schedule of drug administrationFAERS: 133US FAERS
30Feeling abnormalFAERS: 129
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
31Therapeutic response unexpectedFAERS: 129US FAERS
32AnxietyFAERS: 127
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
33Product complaintFAERS: 127
Canada Vigilance: 21
Canada Vigilance
US FAERS
34Throat irritationFAERS: 125
Canada Vigilance: 5
Canada Vigilance
US FAERS
35SinusitisFAERS: 122OFFSIDES
US FAERS
36Medication ErrorFAERS: 114
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Adverse eventFAERS: 113
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Drug administered to patient of inappropriate ageFAERS: 110US FAERS
39Expired product administeredFAERS: 108US FAERS
40Product package associated injuryFAERS: 105US FAERS
41Product dose omissionFAERS: 104
Canada Vigilance: 1
Canada Vigilance
US FAERS
42VomitingFAERS: 99
Canada Vigilance: 3
Canada Vigilance
US FAERS
43CataractFAERS: 96
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
44FatigueFAERS: 94
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
45PainFAERS: 85
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
46RhinalgiaFAERS: 83US FAERS
47PruritusFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Intentional product misuseFAERS: 81US FAERS
49Incorrect drug administration durationFAERS: 75US FAERS
50PneumoniaFAERS: 75
Canada Vigilance: 5
Canada Vigilance
US FAERS
51WheezingFAERS: 75
Canada Vigilance: 2
Canada Vigilance
US FAERS
52Drug ineffective for unapproved indicationFAERS: 72
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Incorrect route of drug administrationFAERS: 70US FAERS
54UrticariaFAERS: 66
Canada Vigilance: 3
Canada Vigilance
US FAERS
55Extra dose administeredFAERS: 65US FAERS
56Burning sensationFAERS: 64OFFSIDES
US FAERS
57Chest discomfortFAERS: 64
Canada Vigilance: 6
Canada Vigilance
US FAERS
58PalpitationsFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
59Chest PainFAERS: 62
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
60ErythemaFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
61Product storage errorFAERS: 61US FAERS
62NasopharyngitisFAERS: 59US FAERS
63Inappropriate schedule of product administrationFAERS: 56US FAERS
64Drug effect incompleteFAERS: 53US FAERS
65Eye painFAERS: 51US FAERS
66Intentional product use issueFAERS: 50US FAERS
67Visual ImpairmentFAERS: 50US FAERS
68SomnolenceFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
69AstheniaFAERS: 45OFFSIDES
US FAERS
70LacerationFAERS: 45US FAERS
71Drug effective for unapproved indicationFAERS: 44US FAERS
72Drug prescribing errorFAERS: 43US FAERS
73Inability to afford medicationFAERS: 43US FAERS
74NervousnessFAERS: 41US FAERS
75VertigoFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Productive CoughFAERS: 40
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
77AphoniaFAERS: 39
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
78BronchitisFAERS: 39OFFSIDES
US FAERS
79Recalled product administeredFAERS: 39US FAERS
80TremorFAERS: 39US FAERS
81Upper-airway cough syndromeFAERS: 39US FAERS
82Drug dispensing errorFAERS: 38US FAERS
83Oral candidiasisFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
84GlaucomaFAERS: 37OFFSIDES
US FAERS
85TinnitusFAERS: 37US FAERS
86Circumstance or information capable of leading to medication errorFAERS: 36US FAERS
87InfluenzaFAERS: 36US FAERS
88Drug DependenceFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
89Sinus headacheFAERS: 34US FAERS
90Contraindicated product administeredFAERS: 33US FAERS
91Eye irritationFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Nonspecific reactionFAERS: 33US FAERS
93DiscomfortFAERS: 32US FAERS
94Back PainFAERS: 31US FAERS
95Product substitution issueFAERS: 30US FAERS
96Abdominal discomfortFAERS: 29OFFSIDES
US FAERS
97Product administered to patient of inappropriate ageFAERS: 29US FAERS
98ArthralgiaFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
99Growth retardationFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Multiple allergiesFAERS: 28US FAERS
101RetchingFAERS: 28US FAERS
102Facial PainFAERS: 27US FAERS
103Product label confusionFAERS: 27US FAERS
104ChokingFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
105Device malfunctionFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
106Ear discomfortFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
107Accidental underdoseFAERS: 25US FAERS
108Pharyngolaryngeal PainFAERS: 25OFFSIDES
US FAERS
109Incorrect product administration durationFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
110ScabFAERS: 24US FAERS
111StomatitisFAERS: 24US FAERS
112AlopeciaFAERS: 23OFFSIDES
US FAERS
113AngerFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
114Euphoric moodFAERS: 22US FAERS
115Accidental overdoseFAERS: 21US FAERS
116MyalgiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Oral painFAERS: 21US FAERS
118RhinitisFAERS: 21US FAERS
119Incorrect product storageFAERS: 20US FAERS
120Middle insomniaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
121Peripheral swellingFAERS: 20US FAERS
122Skin lacerationFAERS: 20OFFSIDES
US FAERS
123Abdominal PainFAERS: 19
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
124Blood glucose increasedFAERS: 19US FAERS
125CryingFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
126InfectionFAERS: 19US FAERS
127Nasal pruritusFAERS: 19US FAERS
128Paranasal sinus discomfortFAERS: 19US FAERS
129Poor quality sleepFAERS: 19US FAERS
130Prescribed underdoseFAERS: 19US FAERS
131BlindnessFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Cerebrovascular accidentFAERS: 18US FAERS
133Increased upper airway secretionFAERS: 18US FAERS
134Lip swellingFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
135SwellingFAERS: 18US FAERS
136Drug exposure during pregnancyFAERS: 17US FAERS
137Feeling jitteryFAERS: 17US FAERS
138LaryngitisFAERS: 17US FAERS
139Nasal inflammationFAERS: 17US FAERS
140Suspected product contaminationFAERS: 17US FAERS
141Head discomfortFAERS: 16US FAERS
142Prescribed overdoseFAERS: 16OFFSIDES
US FAERS
143Pulmonary congestionFAERS: 16US FAERS
144Weight decreasedFAERS: 16US FAERS
145AgitationFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
146ChillsFAERS: 15US FAERS
147DyspepsiaFAERS: 15OFFSIDES
US FAERS
148Product contamination physicalFAERS: 15US FAERS
149Product taste abnormalFAERS: 15US FAERS
150AcneFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Mood swingsFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
152Personality ChangeFAERS: 14
Canada Vigilance: 4
Canada Vigilance
US FAERS
153Sinus painFAERS: 14US FAERS
154SyncopeFAERS: 14US FAERS
155Choking sensationFAERS: 13
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
156InflammationFAERS: 13US FAERS
157LymphadenopathyFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Neck PainFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Oropharyngeal discomfortFAERS: 13US FAERS
160ToothacheFAERS: 13US FAERS
161Blood cortisol decreasedFAERS: 12US FAERS
162CandidiasisFAERS: 12US FAERS
163Cataract operationFAERS: 12OFFSIDES
US FAERS
164Expired drug administeredFAERS: 12US FAERS
165Myocardial InfarctionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Nasal mucosal disorderFAERS: 12US FAERS
167Ocular discomfortFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
168Rash erythematousFAERS: 12US FAERS
169Respiratory tract congestionFAERS: 12US FAERS
170Secretion dischargeFAERS: 12OFFSIDES
US FAERS
171BronchospasmFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Device FailureFAERS: 11OFFSIDES
US FAERS
173Emergency care examinationFAERS: 11US FAERS
174HypotensionFAERS: 11US FAERS
175Incorrect route of product administrationFAERS: 11US FAERS
176Joint swellingFAERS: 11US FAERS
177Therapeutic response unexpected with drug substitutionFAERS: 11US FAERS
178Visual disturbanceFAERS: 11US FAERS
179Dry skinFAERS: 10US FAERS
180FlushingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Thermal burnFAERS: 10US FAERS
182Accidental exposure to product by childFAERS: 9US FAERS
183CheilitisFAERS: 9US FAERS
184ConjunctivitisFAERS: 9US FAERS
185DeafnessFAERS: 9US FAERS
186Emotional disorderFAERS: 9US FAERS
187Exposure via skin contactFAERS: 9US FAERS
188Foreign body in respiratory tractFAERS: 9US FAERS
189Impaired driving abilityFAERS: 9US FAERS
190Impaired work abilityFAERS: 9US FAERS
191LethargyFAERS: 9OFFSIDES
US FAERS
192MydriasisFAERS: 9US FAERS
193PharyngitisFAERS: 9US FAERS
194Product packaging issueFAERS: 9US FAERS
195AmnesiaFAERS: 8US FAERS
196Atrial FibrillationFAERS: 8US FAERS
197Bone painFAERS: 8US FAERS
198Dental cariesFAERS: 8US FAERS
199Device defectiveFAERS: 8US FAERS
200Diabetes MellitusFAERS: 8US FAERS
201DiplopiaFAERS: 8OFFSIDES
US FAERS
202DisabilityFAERS: 8US FAERS
203Drug screen positiveFAERS: 8OFFSIDES
US FAERS
204EczemaFAERS: 8US FAERS
205Eye InfectionFAERS: 8US FAERS
206HypogeusiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
207Initial insomniaFAERS: 8OFFSIDES
US FAERS
208Intercepted medication errorFAERS: 8US FAERS
209Nasal PolypsFAERS: 8US FAERS
210Paranasal sinus hypersecretionFAERS: 8US FAERS
211Product container issueFAERS: 8US FAERS
212Product prescribing errorFAERS: 8US FAERS
213Therapeutic product effect incompleteFAERS: 8US FAERS
214ThrombosisFAERS: 8US FAERS
215Unevaluable eventFAERS: 8US FAERS
216AbasiaFAERS: 7US FAERS
217AphasiaFAERS: 7US FAERS
218Blood glucose decreasedFAERS: 7US FAERS
219ConstipationFAERS: 7US FAERS
220DependenceFAERS: 7OFFSIDES
US FAERS
221DysuriaFAERS: 7US FAERS
222Exposure via ingestionFAERS: 7US FAERS
223General physical health deteriorationFAERS: 7US FAERS
224HypersomniaFAERS: 7US FAERS
225Lower respiratory tract infectionFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
226Memory impairmentFAERS: 7US FAERS
227PallorFAERS: 7US FAERS
228Product contaminationFAERS: 7US FAERS
229Respiratory tract irritationFAERS: 7US FAERS
230TachycardiaFAERS: 7US FAERS
231TensionFAERS: 7US FAERS
232ThirstFAERS: 7US FAERS
233Urinary tract infectionFAERS: 7US FAERS
234treatment failureFAERS: 7US FAERS
235Apparent deathFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
236ArthritisFAERS: 6US FAERS
237ArthropathyFAERS: 6OFFSIDES
US FAERS
238BlepharospasmFAERS: 6US FAERS
239BronchiolitisFAERS: 6OFFSIDES
US FAERS
240Circumstance or information capable of leading to device use errorFAERS: 6US FAERS
241DehydrationFAERS: 6US FAERS
242Depressed Level of ConsciousnessFAERS: 6US FAERS
243DermatitisFAERS: 6US FAERS
244DisorientationFAERS: 6US FAERS
245Drug effect delayedFAERS: 6US FAERS
246Drug effect variableFAERS: 6US FAERS
247Ear congestionFAERS: 6US FAERS
248GlossitisFAERS: 6US FAERS
249Intercepted drug administration errorFAERS: 6US FAERS
250Musculoskeletal stiffnessFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
251Paranasal sinus hyposecretionFAERS: 6US FAERS
252PhotophobiaFAERS: 6US FAERS
253Product use complaintFAERS: 6US FAERS
254Rebound effectFAERS: 6US FAERS
255Skin irritationFAERS: 6US FAERS
256Therapy cessationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
257Vitreous floatersFAERS: 6US FAERS
258Accidental exposureFAERS: 5US FAERS
259AnorexiaFAERS: 5OFFSIDES
US FAERS
260Application site painFAERS: 5US FAERS
261Borderline glaucomaFAERS: 5US FAERS
262Device breakageFAERS: 5US FAERS
263Device leakageFAERS: 5OFFSIDES
US FAERS
264Drug ToleranceFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
265Erectile dysfunctionFAERS: 5US FAERS
266Eye RednessFAERS: 5US FAERS
267Feeling ColdFAERS: 5US FAERS
268HoarsenessFAERS: 5US FAERS
269Incorrect dose administered by deviceFAERS: 5US FAERS
270Increased bronchial secretionFAERS: 5OFFSIDES
US FAERS
271Increased viscosity of upper respiratory secretionFAERS: 5US FAERS
272Intercepted drug dispensing errorFAERS: 5US FAERS
273Mental impairmentFAERS: 5US FAERS
274Ocular HypertensionFAERS: 5US FAERS
275OsteoporosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
276ParanoiaFAERS: 5US FAERS
277PoisoningFAERS: 5US FAERS
278Prescription drug used without a prescriptionFAERS: 5US FAERS
279Product dispensing errorFAERS: 5US FAERS
280RestlessnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
281StressFAERS: 5OFFSIDES
US FAERS
282ThrombocytosisFAERS: 5US FAERS
283Wrong technique in drug usage processFAERS: 5US FAERS
284AngioedemaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
285BedriddenFAERS: 4US FAERS
286Blood Corticotrophin DecreasedFAERS: 4US FAERS
287Blood pressure fluctuationFAERS: 4US FAERS
288Cardiac FlutterFAERS: 4US FAERS
289Drug abuseFAERS: 4US FAERS
290DysarthriaFAERS: 4US FAERS
291DysphemiaFAERS: 4US FAERS
292Emergency CareFAERS: 4US FAERS
293Emotional distressFAERS: 4OFFSIDES
US FAERS
294EnuresisFAERS: 4US FAERS
295Exposure during breast feedingFAERS: 4US FAERS
296Eyelid margin crustingFAERS: 4US FAERS
297Eyelids pruritusFAERS: 4US FAERS
298FlatulenceFAERS: 4US FAERS
299HepatitisFAERS: 4US FAERS
300HyperventilationFAERS: 4US FAERS
301ImmunosuppressionFAERS: 4US FAERS
302Intentional drug misuseFAERS: 4US FAERS
303Maternal exposure during pregnancyFAERS: 4US FAERS
304MyopathyFAERS: 4US FAERS
305Nasal mucosa atrophyFAERS: 4US FAERS
306No adverse eventFAERS: 4US FAERS
307Oral mucosal eruptionFAERS: 4US FAERS
308PleurisyFAERS: 4US FAERS
309PneumonitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
310Product prescribing issueFAERS: 4US FAERS
311Rehabilitation therapyFAERS: 4US FAERS
312Rheumatoid ArthritisFAERS: 4US FAERS
313ScreamingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
314SepsisFAERS: 4US FAERS
315Stevens-Johnson SyndromeFAERS: 4US FAERS
316Tongue blisteringFAERS: 4US FAERS
317Tongue discomfortFAERS: 4US FAERS
318TonsillitisFAERS: 4US FAERS
319Urinary IncontinenceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
320Anaphylactic shockFAERS: 3US FAERS
321Angina PectorisFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
322AsphyxiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
323Autoimmune thyroiditisFAERS: 3US FAERS
324Blood growth hormone decreasedFAERS: 3US FAERS
325Bone density decreasedFAERS: 3US FAERS
326Cardiac ArrestFAERS: 3US FAERS
327CellulitisFAERS: 3OFFSIDES
US FAERS
328CyanosisFAERS: 3US FAERS
329Dark circles under eyesFAERS: 3US FAERS
330Device ineffectiveFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
331Device use issueFAERS: 3US FAERS
332Disease recurrenceFAERS: 3US FAERS
333Drug resistanceFAERS: 3US FAERS
334DysgraphiaFAERS: 3US FAERS
335Electrocardiogram abnormalFAERS: 3US FAERS
336EosinophiliaFAERS: 3US FAERS
337Exposure via eye contactFAERS: 3US FAERS
338Foreign body sensation in eyesFAERS: 3US FAERS
339Gait inabilityFAERS: 3US FAERS
340HungerFAERS: 3US FAERS
341HyperinsulinismFAERS: 3US FAERS
342Hypothalamic pituitary adrenal axis suppressionFAERS: 3US FAERS
343Hypothalamo-pituitary disorderFAERS: 3US FAERS
344IncontinenceFAERS: 3US FAERS
345Insurance issueFAERS: 3US FAERS
346Intentional device misuseFAERS: 3US FAERS
347Intercepted drug prescribing errorFAERS: 3US FAERS
348Intraocular pressure testFAERS: 3US FAERS
349Joint stiffnessFAERS: 3US FAERS
350Limb injuryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
351Limb operationFAERS: 3US FAERS
352Live BirthFAERS: 3US FAERS
353Loss of personal independence in daily activitiesFAERS: 3US FAERS
354Mechanical ventilationFAERS: 3US FAERS
355Medical device complicationFAERS: 3US FAERS
356MonoplegiaFAERS: 3US FAERS
357Muscle strainFAERS: 3US FAERS
358MyopiaFAERS: 3US FAERS
359Night sweatsFAERS: 3US FAERS
360Noninfective gingivitisFAERS: 3US FAERS
361Pain of skinFAERS: 3US FAERS
362PresyncopeFAERS: 3US FAERS
363Product administered at inappropriate siteFAERS: 3US FAERS
364Product dispensing issueFAERS: 3US FAERS
365Product measured potency issueFAERS: 3US FAERS
366Product packaging quantity issueFAERS: 3US FAERS
367Product preparation errorFAERS: 3US FAERS
368Product selection errorFAERS: 3US FAERS
369Pulmonary painFAERS: 3US FAERS
370Quality of life decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
371Reaction to drug excipientsFAERS: 3US FAERS
372Retinal DetachmentFAERS: 3US FAERS
373RetinitisFAERS: 3US FAERS
374RhabdomyolysisFAERS: 3US FAERS
375RosaceaFAERS: 3US FAERS
376Sinonasal obstructionFAERS: 3US FAERS
377Skin UlcerFAERS: 3US FAERS
378Skin reactionFAERS: 3US FAERS
379SomnambulismFAERS: 3US FAERS
380Supraventricular tachycardiaFAERS: 3US FAERS
381Therapeutic product effect decreasedFAERS: 3US FAERS
382Therapeutic response changedFAERS: 3US FAERS
383Therapeutic response delayedFAERS: 3US FAERS
384Tongue erythemaFAERS: 3US FAERS
385Tooth ExtractionFAERS: 3US FAERS
386Viral upper respiratory tract infectionFAERS: 3US FAERS
387Vulvovaginal mycotic infectionFAERS: 3US FAERS
388Wrong drug administeredFAERS: 3US FAERS
389Adrenal atrophyFAERS: 2US FAERS
390Allergic sinusitisFAERS: 2US FAERS
391Angle Closure GlaucomaFAERS: 2OFFSIDES
US FAERS
392Ankle FractureFAERS: 2US FAERS
393Anorectal discomfortFAERS: 2OFFSIDES
US FAERS
394Application site irritationFAERS: 2US FAERS
395Application site scabFAERS: 2US FAERS
396AspergillosisFAERS: 2US FAERS
397AsthenopiaFAERS: 2US FAERS
398Atypical pneumoniaFAERS: 2US FAERS
399Back disorderFAERS: 2OFFSIDES
US FAERS
400BlepharitisFAERS: 2US FAERS
401Blood alcohol increasedFAERS: 2US FAERS
402Blood blisterFAERS: 2US FAERS
403Blood corticotrophin increasedFAERS: 2US FAERS
404Blood cortisol abnormalFAERS: 2US FAERS
405Blood potassium decreasedFAERS: 2US FAERS
406Blood urine presentFAERS: 2US FAERS
407CardiomegalyFAERS: 2US FAERS
408Carpal Tunnel SyndromeFAERS: 2US FAERS
409Cold sweatFAERS: 2US FAERS
410ColitisFAERS: 2US FAERS
411Congenital brain damageFAERS: 2US FAERS
412Cutis LaxaFAERS: 2US FAERS
413Cystic FibrosisFAERS: 2US FAERS
414CystFAERS: 2OFFSIDES
US FAERS
415Decreased immune responsivenessFAERS: 2US FAERS
416DementiaFAERS: 2US FAERS
417Denys-Drash SyndromeFAERS: 2US FAERS
418Depressed moodFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
419Device deployment issueFAERS: 2US FAERS
420Device primingFAERS: 2US FAERS
421Diabetes mellitus inadequate controlFAERS: 2OFFSIDES
US FAERS
422DissociationFAERS: 2US FAERS
423Drug administered at inappropriate siteFAERS: 2US FAERS
424Drug screen false positiveFAERS: 2US FAERS
425Economic problemFAERS: 2OFFSIDES
US FAERS
426Epigastric discomfortFAERS: 2US FAERS
427EpilepsyFAERS: 2US FAERS
428EructationFAERS: 2US FAERS
429Excessive eye blinkingFAERS: 2US FAERS
430Eye allergyFAERS: 2US FAERS
431Eye inflammationFAERS: 2US FAERS
432Eyelid Function DisorderFAERS: 2US FAERS
433Food AllergyFAERS: 2US FAERS
434FrustrationFAERS: 2US FAERS
435Fungal pharyngitisFAERS: 2US FAERS
436GastritisFAERS: 2US FAERS
437Gastrointestinal PainFAERS: 2US FAERS
438Gastrointestinal infectionFAERS: 2US FAERS
439Gene MutationFAERS: 2US FAERS
440General physical condition abnormalFAERS: 2US FAERS
441GingivitisFAERS: 2US FAERS
442Grip strength decreasedFAERS: 2US FAERS
443HemiparesisFAERS: 2OFFSIDES
US FAERS
444Hip DysplasiaFAERS: 2US FAERS
445Hip surgeryFAERS: 2US FAERS
446HyperacusisFAERS: 2US FAERS
447HyperthyroidismFAERS: 2US FAERS
448HypophagiaFAERS: 2US FAERS
449HypospadiasFAERS: 2US FAERS
450ImmobileFAERS: 2US FAERS
451Increased viscosity of bronchial secretionFAERS: 2US FAERS
452Inhalation TherapyFAERS: 2US FAERS
453Intentional dose omissionFAERS: 2US FAERS
454Intentional self-injuryFAERS: 2US FAERS
455Intercepted product dispensing errorFAERS: 2US FAERS
456Intestinal ObstructionFAERS: 2US FAERS
457Intraocular pressure test abnormalFAERS: 2US FAERS
458Irritable Bowel SyndromeFAERS: 2US FAERS
459LeukocytosisFAERS: 2US FAERS
460Limb discomfortFAERS: 2US FAERS
461Lip pruritusFAERS: 2US FAERS
462Liquid product physical issueFAERS: 2US FAERS
463LymphadenitisFAERS: 2US FAERS
464Macular degenerationFAERS: 2US FAERS
465Mastication disorderFAERS: 2US FAERS
466Mental status changesFAERS: 2US FAERS
467Migraine with AuraFAERS: 2US FAERS
468Muscle tightnessFAERS: 2US FAERS
469Musculoskeletal PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
470Musculoskeletal chest painFAERS: 2OFFSIDES
US FAERS
471Musculoskeletal discomfortFAERS: 2OFFSIDES
US FAERS
472NephroblastomaFAERS: 2US FAERS
473Nerve injuryFAERS: 2US FAERS
474NocturiaFAERS: 2US FAERS
475Obsessive-Compulsive DisorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
476Off label use of deviceFAERS: 2US FAERS
477Olfactory Nerve DisorderFAERS: 2US FAERS
478OnychoclasisFAERS: 2US FAERS
479Oral fungal infectionFAERS: 2US FAERS
480Oral pruritusFAERS: 2US FAERS
481Oropharyngeal candidiasisFAERS: 2US FAERS
482Oropharyngitis fungalFAERS: 2US FAERS
483Otitis MediaFAERS: 2US FAERS
484PapuleFAERS: 2US FAERS
485Performance status decreasedFAERS: 2US FAERS
486PertussisFAERS: 2US FAERS
487Poor quality drug administeredFAERS: 2US FAERS
488Product availability issueFAERS: 2US FAERS
489Product counterfeitFAERS: 2US FAERS
490Product dropper issueFAERS: 2US FAERS
491Product label issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
492Product physical issueFAERS: 2US FAERS
493Product supply issueFAERS: 2US FAERS
494Product tamperingFAERS: 2US FAERS
495PsoriasisFAERS: 2US FAERS
496Pulmonary EmbolismFAERS: 2US FAERS
497PurpuraFAERS: 2US FAERS
498Renal massFAERS: 2US FAERS
499Respiratory arrestFAERS: 2US FAERS
500ShockFAERS: 2US FAERS
501Sinus operationFAERS: 2OFFSIDES
US FAERS
502SnoringFAERS: 2US FAERS
503Sputum retentionFAERS: 2US FAERS
504Sudden deathFAERS: 2US FAERS
505Superficial injury of eyeFAERS: 2US FAERS
506TenosynovitisFAERS: 2US FAERS
507Therapy changeFAERS: 2US FAERS
508ThrombocytopeniaFAERS: 2US FAERS
509Tooth ErosionFAERS: 2US FAERS
510Tooth LossFAERS: 2US FAERS
511Toxicity to various agentsFAERS: 2US FAERS
512Unresponsive to stimuliFAERS: 2US FAERS
513Vascular ruptureFAERS: 2US FAERS
514VasculitisFAERS: 2US FAERS
515Vocal Cord ParalysisFAERS: 2US FAERS
516Walking aid userFAERS: 2US FAERS
517White blood cell count decreasedFAERS: 2US FAERS
518Wrong patient received productFAERS: 2US FAERS
519Abdominal tendernessFAERS: 1US FAERS
520Abnormal sleep-related eventFAERS: 1US FAERS
521AbscessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
522ActinomycosisFAERS: 1OFFSIDES
US FAERS
523Activities of daily living impairedFAERS: 1US FAERS
524Acute sinusitisFAERS: 1OFFSIDES
US FAERS
525Adams-Stokes SyndromeFAERS: 1US FAERS
526Administration site discomfortFAERS: 1US FAERS
527Administration site rashFAERS: 1US FAERS
528Adrenal insufficiency neonatalFAERS: 1US FAERS
529Aldolase increasedFAERS: 1US FAERS
530Alopecia AreataFAERS: 1US FAERS
531Altered visual depth perceptionFAERS: 1US FAERS
532AmyloidosisFAERS: 1US FAERS
533Anaphylactoid ReactionFAERS: 1US FAERS
534AnencephalyFAERS: 1US FAERS
535AneurysmFAERS: 1US FAERS
536Antibiotic therapyFAERS: 1US FAERS
537Aortic AneurysmFAERS: 1US FAERS
538Application site drynessFAERS: 1US FAERS
539Application site erythemaFAERS: 1US FAERS
540Application site papulesFAERS: 1US FAERS
541Application site reactionFAERS: 1OFFSIDES
US FAERS
542Application site ulcerFAERS: 1US FAERS
543ArteritisFAERS: 1US FAERS
544Aspergillosis oralFAERS: 1US FAERS
545AuraFAERS: 1US FAERS
546AutoscopyFAERS: 1US FAERS
547Benign Prostatic HyperplasiaFAERS: 1OFFSIDES
US FAERS
548Bilateral breast budsFAERS: 1US FAERS
549BiopsyFAERS: 1US FAERS
550Blood arsenic increasedFAERS: 1US FAERS
551Blood cholesterol increasedFAERS: 1US FAERS
552Blood cortisol increasedFAERS: 1US FAERS
553Blood creatine phosphokinase increasedFAERS: 1US FAERS
554Blood glucose normalFAERS: 1US FAERS
555Blood immunoglobulin E increasedFAERS: 1US FAERS
556Blood pH abnormalFAERS: 1US FAERS
557Blood pressure inadequately controlledFAERS: 1US FAERS
558Blood sodium increasedFAERS: 1US FAERS
559Blood testosterone decreasedFAERS: 1US FAERS
560Blood testosterone increasedFAERS: 1US FAERS
561Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
562Blood uric acid abnormalFAERS: 1US FAERS
563Body fat disorderFAERS: 1US FAERS
564Bone density abnormalFAERS: 1US FAERS
565BradyphreniaFAERS: 1US FAERS
566Breath alcohol test positiveFAERS: 1US FAERS
567Breathing-related sleep disorderFAERS: 1US FAERS
568Bronchial irritationFAERS: 1US FAERS
569Bronchial secretion retentionFAERS: 1US FAERS
570BronchiectasisFAERS: 1US FAERS
571Bronchopulmonary AspergillosisFAERS: 1US FAERS
572BruxismFAERS: 1OFFSIDES
US FAERS
573Buccal mucosal rougheningFAERS: 1US FAERS
574BursitisFAERS: 1OFFSIDES
US FAERS
575CachexiaFAERS: 1US FAERS
576Cardiac assistance device userFAERS: 1US FAERS
577Cartilage injuryFAERS: 1US FAERS
578Central Nervous System InfectionFAERS: 1US FAERS
579Central pain syndromeFAERS: 1US FAERS
580Cervix carcinoma recurrentFAERS: 1US FAERS
581Cholecystitis infectiveFAERS: 1US FAERS
582CholelithiasisFAERS: 1US FAERS
583Chronic sinusitisFAERS: 1OFFSIDES
US FAERS
584Completed SuicideFAERS: 1US FAERS
585Complication associated with deviceFAERS: 1US FAERS
586Concomitant disease aggravatedFAERS: 1US FAERS
587Contraindicated drug prescribedFAERS: 1US FAERS
588Conversion disorderFAERS: 1US FAERS
589Corneal UlcerFAERS: 1US FAERS
590Corneal dystrophyFAERS: 1US FAERS
591Cross InfectionFAERS: 1US FAERS
592Croup infectiousFAERS: 1US FAERS
593DacryocystitisFAERS: 1US FAERS
594Dehydroepiandrosterone decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
595DeliriumFAERS: 1US FAERS
596Dependence on oxygen therapyFAERS: 1US FAERS
597Dermatitis acneiformFAERS: 1US FAERS
598Device damageFAERS: 1US FAERS
599Device deposit issueFAERS: 1US FAERS
600Device difficult to useFAERS: 1US FAERS
601Device operational issueFAERS: 1US FAERS
602DiplegiaFAERS: 1US FAERS
603Discontinued product administeredFAERS: 1US FAERS
604Disease ProgressionFAERS: 1US FAERS
605Disseminated Intravascular CoagulationFAERS: 1US FAERS
606DiverticulitisFAERS: 1OFFSIDES
US FAERS
607Documented hypersensitivity to administered productFAERS: 1US FAERS
608Drug administered in wrong deviceFAERS: 1US FAERS
609Drug dispensed to wrong patientFAERS: 1US FAERS
610Drug exposure via breast milkFAERS: 1US FAERS
611Drug withdrawal syndromeFAERS: 1US FAERS
612Drug-disease interactionFAERS: 1US FAERS
613Dyspnoea exacerbatedFAERS: 1US FAERS
614Educational problemFAERS: 1US FAERS
615Enamel anomalyFAERS: 1US FAERS
616Endodontic procedureFAERS: 1US FAERS
617Eosinophilic PneumoniaFAERS: 1US FAERS
618Epidural lipomatosisFAERS: 1US FAERS
619Epiphyseal injuryFAERS: 1US FAERS
620Erythema MultiformeFAERS: 1US FAERS
621Excessive cerumen productionFAERS: 1US FAERS
622Expired device usedFAERS: 1US FAERS
623Exposure via breast milkFAERS: 1US FAERS
624Exposure via direct contactFAERS: 1US FAERS
625Exposure via inhalationFAERS: 1US FAERS
626Eye opacityFAERS: 1US FAERS
627Eye ulcerFAERS: 1US FAERS
628Fat redistributionFAERS: 1US FAERS
629Foaming at mouthFAERS: 1US FAERS
630Foreign body aspirationFAERS: 1US FAERS
631Frustration tolerance decreasedFAERS: 1US FAERS
632Full blood count increasedFAERS: 1US FAERS
633FumblingFAERS: 1US FAERS
634Gastric ulcerFAERS: 1US FAERS
635GastroenteritisFAERS: 1US FAERS
636Gastrointestinal candidiasisFAERS: 1US FAERS
637Gastrointestinal carcinomaFAERS: 1US FAERS
638Gastrointestinal sounds abnormalFAERS: 1US FAERS
639Gestational DiabetesFAERS: 1US FAERS
640Gingival RecessionFAERS: 1US FAERS
641Gingival erythemaFAERS: 1US FAERS
642Glucocorticoid deficiencyFAERS: 1US FAERS
643Granulomatosis with polyangiitisFAERS: 1US FAERS
644GranulomaFAERS: 1US FAERS
645Hallucinations, mixedFAERS: 1US FAERS
646Heart sounds abnormalFAERS: 1US FAERS
647Heat StrokeFAERS: 1US FAERS
648HerniaFAERS: 1US FAERS
649HomicideFAERS: 1US FAERS
650HordeolumFAERS: 1US FAERS
651Hormone level abnormalFAERS: 1US FAERS
652Hospice CareFAERS: 1US FAERS
653HypervigilanceFAERS: 1US FAERS
654HypokinesiaFAERS: 1OFFSIDES
US FAERS
655HypomaniaFAERS: 1US FAERS
656HypopituitarismFAERS: 1US FAERS
657Iatrogenic injuryFAERS: 1US FAERS
658Immune thrombocytopenic purpuraFAERS: 1US FAERS
659Impaired quality of lifeFAERS: 1US FAERS
660ImpatienceFAERS: 1US FAERS
661Implantable defibrillator insertionFAERS: 1US FAERS
662Inappropriate affectFAERS: 1US FAERS
663Increased tendency to bruiseFAERS: 1US FAERS
664Increased viscosity of nasal secretionFAERS: 1US FAERS
665Infection prophylaxisFAERS: 1US FAERS
666Infective exacerbation of chronic obstructive airways diseaseFAERS: 1US FAERS
667Infective tenosynovitisFAERS: 1US FAERS
668Influenza B virus test positiveFAERS: 1US FAERS
669Instillation site painFAERS: 1US FAERS
670Intentional misuseFAERS: 1US FAERS
671Intercepted product administration errorFAERS: 1US FAERS
672Intercepted product selection errorFAERS: 1US FAERS
673Intervertebral Disc DegenerationFAERS: 1US FAERS
674Intervertebral disc disorderFAERS: 1US FAERS
675Intracranial AneurysmFAERS: 1US FAERS
676Irregular breathingFAERS: 1US FAERS
677Joint injuryFAERS: 1US FAERS
678KeratitisFAERS: 1US FAERS
679Lack of satietyFAERS: 1US FAERS
680Large intestine perforationFAERS: 1US FAERS
681Laryngeal neoplasmFAERS: 1US FAERS
682Latex allergyFAERS: 1US FAERS
683Lichen PlanusFAERS: 1US FAERS
684Lip exfoliationFAERS: 1US FAERS
685Lung perforationFAERS: 1US FAERS
686Lupus pleurisyFAERS: 1US FAERS
687Lymphadenitis bacterialFAERS: 1US FAERS
688Lymphocyte percentage decreasedFAERS: 1US FAERS
689Malabsorption from administration siteFAERS: 1US FAERS
690Malignant neoplasm progressionFAERS: 1US FAERS
691MastectomyFAERS: 1US FAERS
692MeaslesFAERS: 1US FAERS
693Medication residueFAERS: 1US FAERS
694MenopauseFAERS: 1US FAERS
695MetamorphopsiaFAERS: 1OFFSIDES
US FAERS
696MetastasisFAERS: 1US FAERS
697MetrorrhagiaFAERS: 1US FAERS
698Mineral deficiencyFAERS: 1US FAERS
699Mole excisionFAERS: 1US FAERS
700MonoparesisFAERS: 1US FAERS
701Mouth BreathingFAERS: 1US FAERS
702Mouth swellingFAERS: 1US FAERS
703Mucosal painFAERS: 1US FAERS
704Multiple SclerosisFAERS: 1US FAERS
705Muscle RigidityFAERS: 1US FAERS
706Muscular DystrophyFAERS: 1US FAERS
707MyocarditisFAERS: 1US FAERS
708Nasal mucosal hypertrophyFAERS: 1US FAERS
709Neonatal disorderFAERS: 1US FAERS
710NephrolithiasisFAERS: 1OFFSIDES
US FAERS
711Nephrotic SyndromeFAERS: 1OFFSIDES
US FAERS
712NeuralgiaFAERS: 1OFFSIDES
US FAERS
713Neutrophil percentage increasedFAERS: 1US FAERS
714Nipple painFAERS: 1US FAERS
715No reaction on previous exposure to drugFAERS: 1US FAERS
716NoduleFAERS: 1OFFSIDES
US FAERS
717Non-cardiac chest painFAERS: 1OFFSIDES
US FAERS
718NystagmusFAERS: 1US FAERS
719Obsessive thoughtsFAERS: 1US FAERS
720Occupational exposure to productFAERS: 1US FAERS
721Ocular icterusFAERS: 1OFFSIDES
US FAERS
722Oncologic complicationFAERS: 1US FAERS
723Open reduction of fractureFAERS: 1US FAERS
724Oppositional Defiant DisorderFAERS: 1US FAERS
725Optic NeuritisFAERS: 1OFFSIDES
US FAERS
726Oral administration complicationFAERS: 1US FAERS
727Oral infectionFAERS: 1US FAERS
728Oropharyngeal blisteringFAERS: 1US FAERS
729OsteitisFAERS: 1US FAERS
730OsteolysisFAERS: 1US FAERS
731OsteomyelitisFAERS: 1US FAERS
732Osteonecrosis of JawFAERS: 1US FAERS
733OsteopeniaFAERS: 1US FAERS
734OverweightFAERS: 1US FAERS
735Oxygen supplementationFAERS: 1US FAERS
736PO2 decreasedFAERS: 1US FAERS
737Paradoxical drug reactionFAERS: 1US FAERS
738ParotitisFAERS: 1US FAERS
739Perforated ulcerFAERS: 1US FAERS
740Perioral DermatitisFAERS: 1US FAERS
741Periorbital disorderFAERS: 1US FAERS
742Pharyngitis bacterialFAERS: 1US FAERS
743Physical abuseFAERS: 1US FAERS
744Pityriasis RoseaFAERS: 1US FAERS
745Pleuritic painFAERS: 1US FAERS
746PneumothoraxFAERS: 1US FAERS
747PolyarthritisFAERS: 1US FAERS
748PolychondritisFAERS: 1US FAERS
749Poor quality device usedFAERS: 1US FAERS
750Precocious PubertyFAERS: 1US FAERS
751PregnancyFAERS: 1US FAERS
752Product administration errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
753Product communication issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
754Product container seal issueFAERS: 1US FAERS
755Product contamination microbialFAERS: 1US FAERS
756Product expiration date issueFAERS: 1US FAERS
757Product lot number issueFAERS: 1US FAERS
758Product name confusionFAERS: 1US FAERS
759Product outer packaging issueFAERS: 1US FAERS
760Product packaging confusionFAERS: 1US FAERS
761Product preparation issueFAERS: 1US FAERS
762Product shape issueFAERS: 1US FAERS
763Product substitution errorFAERS: 1US FAERS
764Protein urine presentFAERS: 1US FAERS
765PrurigoFAERS: 1US FAERS
766Pulmonary HypertensionFAERS: 1US FAERS
767Pulmonary function test decreasedFAERS: 1US FAERS
768Pulmonary thrombosisFAERS: 1US FAERS
769PyodermaFAERS: 1US FAERS
770Pyogenic granulomaFAERS: 1US FAERS
771Reaction to excipientFAERS: 1US FAERS
772Reaction to preservativesFAERS: 1US FAERS
773Rectal dischargeFAERS: 1US FAERS
774Reflux laryngitisFAERS: 1US FAERS
775Removal of foreign body from eyeFAERS: 1US FAERS
776Renal painFAERS: 1US FAERS
777Respiratory FailureFAERS: 1OFFSIDES
US FAERS
778Respiratory distressFAERS: 1US FAERS
779Respiratory tract infection viralFAERS: 1US FAERS
780Retinal pigmentationFAERS: 1US FAERS
781Retinal vascular occlusionFAERS: 1US FAERS
782Retrograde amnesiaFAERS: 1US FAERS
783SarcoidosisFAERS: 1OFFSIDES
US FAERS
784SarcomaFAERS: 1US FAERS
785Scarlet FeverFAERS: 1US FAERS
786School refusalFAERS: 1US FAERS
787ScleritisFAERS: 1US FAERS
788Sensitive skinFAERS: 1US FAERS
789Sensitivity to weather changeFAERS: 1US FAERS
790Sensory level abnormalFAERS: 1US FAERS
791Sexual DysfunctionFAERS: 1US FAERS
792Skin ErosionFAERS: 1US FAERS
793Skin IndurationFAERS: 1US FAERS
794Skin PapillomaFAERS: 1US FAERS
795Skin lesionFAERS: 1US FAERS
796Soft tissue swellingFAERS: 1US FAERS
797Spinal column injuryFAERS: 1US FAERS
798Spinal fusion surgeryFAERS: 1US FAERS
799Spirometry abnormalFAERS: 1US FAERS
800Steroid activityFAERS: 1US FAERS
801Stroke in evolutionFAERS: 1US FAERS
802Subcutaneous AbscessFAERS: 1US FAERS
803Suicide attemptFAERS: 1US FAERS
804SunburnFAERS: 1US FAERS
805Suspected counterfeit productFAERS: 1US FAERS
806Suspected transmission of an infectious agent via productFAERS: 1US FAERS
807Swollen tear ductFAERS: 1US FAERS
808TachyphreniaFAERS: 1US FAERS
809TachyphylaxisFAERS: 1US FAERS
810TalipesFAERS: 1US FAERS
811Therapeutic product contaminationFAERS: 1US FAERS
812Therapeutic product effect delayedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
813Therapeutic product effective for unapproved indicationFAERS: 1US FAERS
814Thought insertionFAERS: 1US FAERS
815Throat clearingFAERS: 1US FAERS
816Tongue pruritusFAERS: 1US FAERS
817Tooth InfectionFAERS: 1US FAERS
818Tooth ResorptionFAERS: 1US FAERS
819Toxic Epidermal NecrolysisFAERS: 1US FAERS
820Tracheal StenosisFAERS: 1US FAERS
821TracheomalaciaFAERS: 1US FAERS
822TrichotillomaniaFAERS: 1US FAERS
823Trigeminal NeuralgiaFAERS: 1US FAERS
824Trisomy 21FAERS: 1US FAERS
825TuberculosisFAERS: 1US FAERS
826Tympanic Membrane PerforationFAERS: 1US FAERS
827Ulnar tunnel syndromeFAERS: 1US FAERS
828UnemploymentFAERS: 1US FAERS
829Upper respiratory fungal infectionFAERS: 1US FAERS
830Upper respiratory tract congestionFAERS: 1US FAERS
831Urine flow decreasedFAERS: 1US FAERS
832Vagal nerve stimulator implantationFAERS: 1US FAERS
833Vasculitic rashFAERS: 1US FAERS
834Vena cava injuryFAERS: 1US FAERS
835Viral pharyngitisFAERS: 1US FAERS
836VitritisFAERS: 1US FAERS
837Wound InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
838Wrong doseFAERS: 1US FAERS
839Wrong patient received medicationFAERS: 1US FAERS
840YawningFAERS: 1US FAERS
841angiogramFAERS: 1US FAERS
842cancer surgeryFAERS: 1US FAERS
843colonoscopyFAERS: 1OFFSIDES
US FAERS
844intensive careFAERS: 1US FAERS
845muscle injuryFAERS: 1US FAERS
846nervous system disorderFAERS: 1US FAERS
847skin abrasionFAERS: 1US FAERS
848Abdominal InfectionOFFSIDES
849Acid refluxOFFSIDES
850Actinic keratosisOFFSIDES
851Acute Coronary SyndromeOFFSIDES
852Acute bronchitisOFFSIDES
853Acute myocardial infarctionOFFSIDES
854Acute prerenal failureOFFSIDES
855Acute respiratory failureOFFSIDES
856AdenocarcinomaOFFSIDES
857AgraphiaOFFSIDES
858Alcoholic IntoxicationOFFSIDES
859AlveolitisOFFSIDES
860AmenorrheaOFFSIDES
861Ammonia increasedOFFSIDES
862AnhedoniaOFFSIDES
863AnhidrosisOFFSIDES
864ApathyOFFSIDES
865ApneaOFFSIDES
866AppendectomyOFFSIDES
867AppendicitisOFFSIDES
868Application site rashCanada Vigilance: 1Canada Vigilance
869Application site swellingCanada Vigilance: 1Canada Vigilance
870ArteriosclerosisOFFSIDES
871ArthrodesisOFFSIDES
872AscitesOFFSIDES
873Aspartate aminotransferase abnormalOFFSIDES
874Aspiration PneumoniaOFFSIDES
875AtelectasisOFFSIDES
876Avascular necrosisOFFSIDES
877Bacterial test positiveOFFSIDES
878Bed restCanada Vigilance: 1Canada Vigilance
879BereavementOFFSIDES
880Biopsy breast abnormalOFFSIDES
881Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
882Blood GlucoseOFFSIDES
883Blood cholesterolOFFSIDES
884Blood triglycerides increasedOFFSIDES
885Blurred visionOFFSIDES
886Bone marrow depressionOFFSIDES
887Brain ConcussionOFFSIDES
888Breakthrough PainOFFSIDES
889Breast CystOFFSIDES
890Breast fibromaOFFSIDES
891Bronchial ObstructionOFFSIDES
892Bronchoalveolar lavage abnormalOFFSIDES
893CD4 Lymphocytes DecreasedOFFSIDES
894CalcinosisOFFSIDES
895Cardioactive drug levelOFFSIDES
896Cerebral ThrombosisOFFSIDES
897Cerebral artery occlusionOFFSIDES
898Cervicobrachial syndromeOFFSIDES
899Chest wall painOFFSIDES
900CholecystitisOFFSIDES
901ChromaturiaOFFSIDES
902Chronic Obstructive Airway DiseaseOFFSIDES
903CirrhosisOFFSIDES
904Cluster HeadacheOFFSIDES
905Color blindnessOFFSIDES
906Complications of transplant surgeryOFFSIDES
907Compression fractureOFFSIDES
908ConfabulationOFFSIDES
909DemyelinationOFFSIDES
910Dental abscessOFFSIDES
911Device related infectionOFFSIDES
912DiabetesOFFSIDES
913Diaphragmatic HerniaOFFSIDES
914Dissociative Identity DisorderOFFSIDES
915Diverticular perforationOFFSIDES
916DysphasiaOFFSIDES
917Ejection Fraction DecreasedOFFSIDES
918EndocarditisOFFSIDES
919Endocervical curettageOFFSIDES
920Endometrial disorderOFFSIDES
921Epinephrine increasedOFFSIDES
922Essential HypertensionOFFSIDES
923ExcoriationOFFSIDES
924Feeding problem in childOFFSIDES
925Feeling of body temperature changeCanada Vigilance: 1Canada Vigilance
926Femoral artery occlusionOFFSIDES
927FibromyalgiaOFFSIDES
928Flank PainOFFSIDES
929FormicationOFFSIDES
930GamblingOFFSIDES
931GangreneOFFSIDES
932GoutOFFSIDES
933GranulocytosisOFFSIDES
934HemicephalalgiaOFFSIDES
935Hepatitis COFFSIDES
936HypercapniaOFFSIDES
937HyperparathyroidismOFFSIDES
938Hypertensive heart diseaseOFFSIDES
939Hypocoagulable stateOFFSIDES
940HypoxiaOFFSIDES
941HysteroscopyOFFSIDES
942Idiosyncratic drug reactionOFFSIDES
943Intention tremorOFFSIDES
944Kidney FailureOFFSIDES
945LaryngospasmCanada Vigilance: 1Canada Vigilance
946LegionellaOFFSIDES
947Liver transplant rejectionOFFSIDES
948Long QT SyndromeOFFSIDES
949LymphedemaOFFSIDES
950Malignant neoplasm of spinal cordOFFSIDES
951Markedly reduced dietary intakeOFFSIDES
952Mass excisionOFFSIDES
953Modified radical mastectomyOFFSIDES
954Multiple sclerosis relapseOFFSIDES
955Muscle WeaknessOFFSIDES
956Negative thoughtsCanada Vigilance: 2Canada Vigilance
957Nephrogenic Fibrosing DermopathyOFFSIDES
958Nervous tensionOFFSIDES
959Neutropenic sepsisOFFSIDES
960Nodal osteoarthritisOFFSIDES
961ObesityCanada Vigilance: 1Canada Vigilance
962OrthopneaOFFSIDES
963Panic DisorderOFFSIDES
964PeriarthritisOFFSIDES
965Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
966PlatybasiaOFFSIDES
967Poor peripheral circulationOFFSIDES
968Post lumbar puncture syndromeOFFSIDES
969Post procedural nauseaOFFSIDES
970Postmenopausal bleedingOFFSIDES
971Postoperative wound complicationOFFSIDES
972PriapismOFFSIDES
973Procedural site reactionOFFSIDES
974Progesterone receptor assayOFFSIDES
975Protein total increasedOFFSIDES
976PseudocystOFFSIDES
977PyelonephritisOFFSIDES
978Rebound nasal congestionCanada Vigilance: 1Canada Vigilance
979Rectal examination abnormalOFFSIDES
980Renal cystOFFSIDES
981Renal tubular necrosisOFFSIDES
982RhinorrheaOFFSIDES
983SerositisOFFSIDES
984Shoulder PainOFFSIDES
985Sinus bradycardiaOFFSIDES
986Spinal column stenosisOFFSIDES
987Spinal rod insertionOFFSIDES
988Stress at workOFFSIDES
989Superinfection lungOFFSIDES
990Tension HeadacheOFFSIDES
991Therapy non-responderOFFSIDES
992Tinea PedisOFFSIDES
993TracheobronchitisOFFSIDES
994UlcerOFFSIDES
995Umbilical hernia perforationOFFSIDES
996Umbilical herniaOFFSIDES
997Uterine PolypOFFSIDES
998Vaginal lesionOFFSIDES
999Venous stasisOFFSIDES
1000Ventricular FibrillationOFFSIDES
1001Violence-related symptomCanada Vigilance: 1Canada Vigilance
1002Wound infection bacterialOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.